Engineering CRISPR nanoplatforms to deplete cancer stem cells: Delivery checkpoints, target plasticity, and clinical viability

Selvakumar Chandrasekaran, Nallusamy Duraisamy, Manjunathan Jagadeesan, Yashwanth Kumar Palukuri, Silambarasan Tamilselvan

Open source

DOI: 10.1016/j.nano.2026.103007
Published: 2026-09
Container: Nanomedicine: Nanotechnology, Biology and Medicine
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.nano.2026.103007,
  title = {Engineering CRISPR nanoplatforms to deplete cancer stem cells: Delivery checkpoints, target plasticity, and clinical viability},
  author = {Selvakumar Chandrasekaran and Nallusamy Duraisamy and Manjunathan Jagadeesan and Yashwanth Kumar Palukuri and Silambarasan Tamilselvan},
  year = {2026},
  journal = {Nanomedicine: Nanotechnology, Biology and Medicine},
  doi = {10.1016/j.nano.2026.103007},
  url = {https://doi.org/10.1016/j.nano.2026.103007}
}

RIS

TY  - JOUR
TI  - Engineering CRISPR nanoplatforms to deplete cancer stem cells: Delivery checkpoints, target plasticity, and clinical viability
AU  - Selvakumar Chandrasekaran
AU  - Nallusamy Duraisamy
AU  - Manjunathan Jagadeesan
AU  - Yashwanth Kumar Palukuri
AU  - Silambarasan Tamilselvan
PY  - 2026
JO  - Nanomedicine: Nanotechnology, Biology and Medicine
DO  - 10.1016/j.nano.2026.103007
UR  - https://doi.org/10.1016/j.nano.2026.103007
ER  -

APA

Chandrasekaran, S., Duraisamy, N., Jagadeesan, M., Palukuri, Y. K., & Tamilselvan, S. (2026). Engineering CRISPR nanoplatforms to deplete cancer stem cells: Delivery checkpoints, target plasticity, and clinical viability. Nanomedicine: Nanotechnology, Biology and Medicine. https://doi.org/10.1016/j.nano.2026.103007

Source records

crossref · retrieved 2026-09-26T03:28:35.895Z